Intravenous immunoglobulin in two children with Guillain-Barré syndrome.
作者信息
Notarangelo L D, Duse M, Tiberti S, Guarneri B, Brunori A, Negrini A, Ugazio A G
机构信息
Department of Paediatrics, University of Brescia, Italy.
出版信息
Eur J Pediatr. 1993 Apr;152(4):372-4. doi: 10.1007/BF01956757.
PMID:8482293
Abstract
Two children with Guillain-Barrè syndrome were successfully treated with high-dose intravenous immunoglobulin (IVIG) and no relapses occurred over a 1 year follow up. No side-effects were observed. These data provide further evidence that IVIG may be safely and effectively employed in children with Guillain-Barrè syndrome.
摘要
Zotero 插件